Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. - Wikidata - wikimedia - TriplyDB

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

http://www.wikidata.org/entity/Q37324783

about

Vogt-Koyanagi-Harada syndrome - current perspectives.FGFR1OP tagSNP but not CCR6 polymorphisms are associated with Vogt-Koyanagi-Harada syndrome in Chinese Han Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data.Current approach in the diagnosis and management of panuveitis.The role of T cells in autoimmune uveitis.Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease Sequence analysis of four vitamin D family genes (VDR, CYP24A1, CYP27B1 and CYP2R1) in Vogt-Koyanagi-Harada (VKH) patients: identification of a potentially pathogenic variant in CYP2R1 Association of Vogt Koyanagi Harada Syndrome and Seronegative Rheumatoid Arthritis.PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome Immunotherapy of autoimmunity and cancer: the penalty for success.HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.Case Report: Behçet's disease accompanied with vitiligo.Trabecular meshwork depigmentation in Vogt-Koyanagi-Harada disease.Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey.Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.

P2860

Q28072882-6FF00443-13D6-435F-92C9-F75CAC7ED11C Q31126119-6DFC9330-075E-4754-B192-143487DD3527 Q31151178-A01ED63A-A7BB-42CC-9C80-2201117F7903 Q33737954-3A54947A-E1A2-453C-A7CB-CB70A082E1F2 Q34027100-13EA8FC2-C500-46CF-9DD9-70BBEA208970 Q35593900-87AEF7D0-3527-4636-B944-E08268B7D411 Q36157081-4F631C96-792A-4F5E-9CA6-C7E91A618179 Q36893486-172F9023-9492-42AB-82D5-845891CD49AC Q37104878-4EC1F132-7291-49E7-BA05-1A4D06B85B83 Q37325451-6847F15E-D866-4B57-8ECF-667EC7D09A2D Q37346466-3382B13A-C823-47EA-AF16-C72D38C01F0C Q38591885-90149A73-48E9-42CB-AA0F-5E4860472695 Q40127737-0CE98857-16E3-477A-B53B-BFA01E2761F9 Q42062212-AEF872BE-AE5A-4D85-B1E0-B3600BE4C1ED Q45928295-3D6862E2-58BD-40B5-80A4-346B31C884BD Q50098055-B2B567FB-D1BA-474B-B23B-E70DAD55C8CC Q51177631-7C266272-CA0B-4FA9-AE51-5170BB72A957 Q54453981-F150FA77-1769-46F4-A522-425A8E6F2ACF

P2860

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

http://www.wikidata.org/entity/Q37324783

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh

1996年學術文章

@zh-hant

name

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

@en

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

@nl

type

label

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

@en

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

@nl

prefLabel

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

@en

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

@nl

P1433

Q37324783-847BFCAE-FDAE-4E11-A5BF-077C2D897C07

P1476

Q37324783-A34389BD-D618-44EC-8445-27720984AECE

P2093

Q37324783-1B79B4DE-F0A7-4BEA-B7C6-51ADD0588745

Q37324783-B88E2119-791D-440B-9EAC-21F475CF350D

P2860

Q37324783-0A17763A-4052-4E21-869C-69A5C9C64EC2

Q37324783-0A2EE203-21FA-42DD-9B91-0A949ABBB936

Q37324783-0A845836-45F4-4149-BA93-220C4148BAB3

Q37324783-0E8CF287-B2C3-4A5A-B736-12476A23E491

Q37324783-147DBECE-C1A9-4B55-AC33-2361F707544A

Q37324783-182F12D9-2683-431D-9471-0FFE03F3DB7B

Q37324783-23210D0B-4489-4ECB-9F5F-852C879FF073

Q37324783-2DBCF128-CA29-4A1A-B502-ABA7C32074D7

Q37324783-5379C973-808E-4AC5-A9A6-9A30578A2E56

Q37324783-5FE42ABA-1B20-42EE-A1BE-0031D6CD8168

P304

Q37324783-C793ACEE-6054-4EEB-896E-9466775C1FA4

P31

Q37324783-AAF286FF-7B8A-43D5-A9BD-C829F1A48252

P356

Q37324783-6C862971-16E7-4BAF-818B-F7988F5AC3EA

P407

Q37324783-123BA17E-82AC-4254-AD78-D6148B034C6E

P433

Q37324783-A26942EF-5EAF-48A9-B75D-7EEABE1FD27F

P478

Q37324783-C95D65E0-E22A-48E9-8831-65CD4113D93B

P577

Q37324783-5F258697-D702-4227-858F-D95184933558

P5875

Q37324783-1F88ACA4-62CD-4C64-86D1-68BE7201B2B3

P698

Q37324783-7F12CF17-0398-44A2-BB52-F48976647C33

P921

Q37324783-3B422956-9EFD-4BF7-99F6-FA641BE0FA6B

Q37324783-A93A7FA2-E1CF-4EF1-B326-E0326106AAE4

P932

Q37324783-876F25C8-08C8-4772-BC7D-292BDF5FCB21

P356

P1433

British Journal of Ophthalmology

P1476

Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

@en

P2093

Norose K

http://www.w3.org/2001/XMLSchema#string

Yano A

http://www.w3.org/2001/XMLSchema#string

P2860

Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology.

Cytokines and uveitis, a review.

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.

The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species.

Interleukin-2: inception, impact, and implications.

Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.

Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.

Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures.

Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells.

P304

1002-1008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.80.11.1002

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

1996-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14230683

http://www.w3.org/2001/XMLSchema#string

P698

8976730

http://www.w3.org/2001/XMLSchema#string

P921

P932

505680

http://www.w3.org/2001/XMLSchema#string